Only biotechwith 2 Myron'son theleadershipteamMino-Lokpotentialmarket>$1BWe haveenough cashto go wellinto 2023We willhaveexclusivityWe had aphase 2btrial with100%efficacyI/ONTAK'spotentialmarket is>$300mAn actualiMSCupdateI'm ashareholdermyselfThere are noFDAapproveddrugs to treathemorrhoidsI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Not manycompaniesthis size with2 late stageassetsMino-WrapWe intendto submita BLA in2H 2022I/ONTAKwas thebest deal Iever madeThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"Myron Holubiakand I founded aprivatecompany in2013Mino-Lokis our leadassetHemorrhoidsis a $2BmarketWe expect tofinish theMino-Loktrial this yearI won't diluteshareholdersI/ONTAKis our leadassetWe will openupinternationalsites forMino-Lok trialInsidersinvested$26.5mOur Halo-Lido trial willhave finalpatient byend of 2022Only biotechwith 2 Myron'son theleadershipteamMino-Lokpotentialmarket>$1BWe haveenough cashto go wellinto 2023We willhaveexclusivityWe had aphase 2btrial with100%efficacyI/ONTAK'spotentialmarket is>$300mAn actualiMSCupdateI'm ashareholdermyselfThere are noFDAapproveddrugs to treathemorrhoidsI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Not manycompaniesthis size with2 late stageassetsMino-WrapWe intendto submita BLA in2H 2022I/ONTAKwas thebest deal Iever madeThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"Myron Holubiakand I founded aprivatecompany in2013Mino-Lokis our leadassetHemorrhoidsis a $2BmarketWe expect tofinish theMino-Loktrial this yearI won't diluteshareholdersI/ONTAKis our leadassetWe will openupinternationalsites forMino-Lok trialInsidersinvested$26.5mOur Halo-Lido trial willhave finalpatient byend of 2022

Leonard Mazur HCW Conference - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Only biotech with 2 Myron's on the leadership team
  2. Mino-Lok potential market >$1B
  3. We have enough cash to go well into 2023
  4. We will have exclusivity
  5. We had a phase 2b trial with 100% efficacy
  6. I/ONTAK's potential market is >$300m
  7. An actual iMSC update
  8. I'm a shareholder myself
  9. There are no FDA approved drugs to treat hemorrhoids
  10. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  11. Not many companies this size with 2 late stage assets
  12. Mino-Wrap
  13. We intend to submit a BLA in 2H 2022
  14. I/ONTAK was the best deal I ever made
  15. The name Citius comes from the Olympic motto "Citius,Altius Fortius"
  16. Myron Holubiak and I founded a private company in 2013
  17. Mino-Lok is our lead asset
  18. Hemorrhoids is a $2B market
  19. We expect to finish the Mino-Lok trial this year
  20. I won't dilute shareholders
  21. I/ONTAK is our lead asset
  22. We will open up international sites for Mino-Lok trial
  23. Insiders invested $26.5m
  24. Our Halo-Lido trial will have final patient by end of 2022